Deal-Making
AstraZeneca ups CGT interest through $1bn Pfizer deal
Deal MakingAstraZeneca ups CGT interest through $1bn Pfizer dealAstraZeneca ups CGT interest through $1bn Pfizer deal
Through its Alexion business, AstraZeneca will add a portfolio of preclinical gene therapies from fellow big pharma firm Pfizer.